Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q0BV
|
||||
Former ID |
DNC009213
|
||||
Drug Name |
Naphthalen-2-yl 10H-phenothiazine-10-carboxylate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H15NO2S
|
||||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)OC(=O)N3C4=CC=CC=C4SC5=CC=CC=C53
|
||||
InChI |
1S/C23H15NO2S/c25-23(26-18-14-13-16-7-1-2-8-17(16)15-18)24-19-9-3-5-11-21(19)27-22-12-6-4-10-20(22)24/h1-15H
|
||||
InChIKey |
DFCQYZLDLAWXGY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | J Med Chem. 2008 Jul 24;51(14):4200-12. Epub 2008 Jun 21.Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.